126 related articles for article (PubMed ID: 17714026)
1. HU-331: a cannabinoid quinone, with uncommon cytotoxic properties and low toxicity.
Peters M; Kogan NM
Expert Opin Investig Drugs; 2007 Sep; 16(9):1405-13. PubMed ID: 17714026
[TBL] [Abstract][Full Text] [Related]
2. A cannabinoid quinone inhibits angiogenesis by targeting vascular endothelial cells.
Kogan NM; Blázquez C; Alvarez L; Gallily R; Schlesinger M; Guzmán M; Mechoulam R
Mol Pharmacol; 2006 Jul; 70(1):51-9. PubMed ID: 16571653
[TBL] [Abstract][Full Text] [Related]
3. A cannabinoid anticancer quinone, HU-331, is more potent and less cardiotoxic than doxorubicin: a comparative in vivo study.
Kogan NM; Schlesinger M; Peters M; Marincheva G; Beeri R; Mechoulam R
J Pharmacol Exp Ther; 2007 Aug; 322(2):646-53. PubMed ID: 17478614
[TBL] [Abstract][Full Text] [Related]
4. HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitor.
Kogan NM; Schlesinger M; Priel E; Rabinowitz R; Berenshtein E; Chevion M; Mechoulam R
Mol Cancer Ther; 2007 Jan; 6(1):173-83. PubMed ID: 17237277
[TBL] [Abstract][Full Text] [Related]
5. Monocyclic Quinone Structure-Activity Patterns: Synthesis of Catalytic Inhibitors of Topoisomerase II with Potent Antiproliferative Activity.
Waugh TM; Masters J; Aliev AE; Marson CM
ChemMedChem; 2020 Jan; 15(1):114-124. PubMed ID: 31778038
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid Quinones-A Review and Novel Observations.
Kogan NM; Peters M; Mechoulam R
Molecules; 2021 Mar; 26(6):. PubMed ID: 33801057
[TBL] [Abstract][Full Text] [Related]
7. HU-331 and Oxidized Cannabidiol Act as Inhibitors of Human Topoisomerase IIα and β.
Wilson JT; Fief CA; Jackson KD; Mercer SL; Deweese JE
Chem Res Toxicol; 2018 Feb; 31(2):137-144. PubMed ID: 29272108
[TBL] [Abstract][Full Text] [Related]
8. HU-331 is a catalytic inhibitor of topoisomerase IIα.
Regal KM; Mercer SL; Deweese JE
Chem Res Toxicol; 2014 Dec; 27(12):2044-51. PubMed ID: 25409338
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitumor activity of quinonoid derivatives of cannabinoids.
Kogan NM; Rabinowitz R; Levi P; Gibson D; Sandor P; Schlesinger M; Mechoulam R
J Med Chem; 2004 Jul; 47(15):3800-6. PubMed ID: 15239658
[TBL] [Abstract][Full Text] [Related]
10. A novel synthetic, nonpsychoactive cannabinoid acid (HU-320) with antiinflammatory properties in murine collagen-induced arthritis.
Sumariwalla PF; Gallily R; Tchilibon S; Fride E; Mechoulam R; Feldmann M
Arthritis Rheum; 2004 Mar; 50(3):985-98. PubMed ID: 15022343
[TBL] [Abstract][Full Text] [Related]
11. Antihyperalgesic effect of a Cannabis sativa extract in a rat model of neuropathic pain: mechanisms involved.
Comelli F; Giagnoni G; Bettoni I; Colleoni M; Costa B
Phytother Res; 2008 Aug; 22(8):1017-24. PubMed ID: 18618522
[TBL] [Abstract][Full Text] [Related]
12. The reactivity of o-quinones which do not isomerize to quinone methides correlates with alkylcatechol-induced toxicity in human melanoma cells.
Bolton JL; Pisha E; Shen L; Krol ES; Iverson SL; Huang Z; van Breemen RB; Pezzuto JM
Chem Biol Interact; 1997 Sep; 106(2):133-48. PubMed ID: 9366899
[TBL] [Abstract][Full Text] [Related]
13. Synthetic cannabinoid quinones: preparation, in vitro antiproliferative effects and in vivo prostate antitumor activity.
Morales P; Vara D; Goméz-Cañas M; Zúñiga MC; Olea-Azar C; Goya P; Fernández-Ruiz J; Díaz-Laviada I; Jagerovic N
Eur J Med Chem; 2013; 70():111-9. PubMed ID: 24141201
[TBL] [Abstract][Full Text] [Related]
14. The Oxidation of Phytocannabinoids to Cannabinoquinoids.
Caprioglio D; Mattoteia D; Pollastro F; Negri R; Lopatriello A; Chianese G; Minassi A; Collado JA; Munoz E; Taglialatela-Scafati O; Appendino G
J Nat Prod; 2020 May; 83(5):1711-1715. PubMed ID: 32315173
[TBL] [Abstract][Full Text] [Related]
15. HU-446 and HU-465, Derivatives of the Non-psychoactive Cannabinoid Cannabidiol, Decrease the Activation of Encephalitogenic T Cells.
Kozela E; Haj C; Hanuš L; Chourasia M; Shurki A; Juknat A; Kaushansky N; Mechoulam R; Vogel Z
Chem Biol Drug Des; 2016 Jan; 87(1):143-53. PubMed ID: 26259697
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic and antioxidant marine prenylated quinones and hydroquinones.
Sunassee SN; Davies-Coleman MT
Nat Prod Rep; 2012 May; 29(5):513-35. PubMed ID: 22382850
[TBL] [Abstract][Full Text] [Related]
17. Comparative assessment of antimicrobial, antiradical and cytotoxic activities of cannabidiol and its propyl analogue cannabidivarin.
Russo C; Lavorgna M; Nugnes R; Orlo E; Isidori M
Sci Rep; 2021 Nov; 11(1):22494. PubMed ID: 34795379
[TBL] [Abstract][Full Text] [Related]
18. Formation and Biological Targets of Quinones: Cytotoxic versus Cytoprotective Effects.
Bolton JL; Dunlap T
Chem Res Toxicol; 2017 Jan; 30(1):13-37. PubMed ID: 27617882
[TBL] [Abstract][Full Text] [Related]
19. Cannabidiol oxidation product HU-331 is a potential anticancer cannabinoid-quinone: a narrative review.
Trac J; Keck JM; Deweese JE
J Cannabis Res; 2021 Apr; 3(1):11. PubMed ID: 33892826
[TBL] [Abstract][Full Text] [Related]
20. Effects of cannabinoids Δ(9)-tetrahydrocannabinol, Δ(9)-tetrahydrocannabinolic acid and cannabidiol in MPP+ affected murine mesencephalic cultures.
Moldzio R; Pacher T; Krewenka C; Kranner B; Novak J; Duvigneau JC; Rausch WD
Phytomedicine; 2012 Jun; 19(8-9):819-24. PubMed ID: 22571976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
